Angola unveils a €30 million blue economy initiative to strengthen fisheries, boost sustainability, and diversify economic growth.
Novartis receives positive CHMP support for Itvisma, expanding spinal muscular atrophy gene therapy access across multiple age groups in Europe.
German healthcare technology company ETERNO has secured investment from Verdane to expand its AI-native outpatient care platform, improving healthcare efficiency and digital transformation across Germany.
Labcorp and Epic have expanded their partnership to streamline lab ordering, improve healthcare efficiency, and increase access to advanced diagnostic and genetic testing across U.S. health systems.
Thermo Fisher Scientific and RealBio have signed a strategic partnership to enhance IVD quality control solutions in China. The collaboration supports innovation, regulatory compliance, and faster commercialization for diagnostic manufacturers.
Discover how Celanese drives innovation, operational efficiency, and customer-centric manufacturing to achieve sustainable business growth.
Google Quantum AI launches the REPLIQA research program with a $10 million investment to advance quantum computing, AI, and biology research across leading U.S. universities.
Virtual Science AI unveils Medical Competitor AI, helping pharma companies track competitor activity, analyze scientific narratives, and improve product launch success with real-time insights.
Japan is leading innovation in cell therapy with iPS-based immune cell treatments for solid tumors and Parkinsons disease. The Japan cell therapy market is expected to grow rapidly through 2035.
Scientists have developed a smart metal implant that promotes healing, reduces complications, and safely dissolves in the body over time.
Hartford HealthCare and Cadence have partnered to expand AI-powered remote care, providing chronic disease monitoring, preventive care, and personalized support for seniors at home.
TDB-DST has partnered with Helix Cell Therapeutics to develop an advanced dual-targeting CAR-T cell therapy for Multiple Myeloma, aiming to improve treatment outcomes and strengthen India biotechnology ecosystem.
WellSky has partnered with Unison Health Services to deploy SkySense AI, helping reduce clinician documentation workload, improve workforce retention, and enhance patient care across Los Angeles home healthcare services.
IMP Software and Yapily introduce open banking-based reconciliation solutions for the education sector to improve financial efficiency.
Jittery Joes Coffee teams up with Peter Dale to introduce the new Kokoro Matcha Latte, blending premium matcha with innovative flavor.
BREZTRI has received US approval as the first and only single-inhaler triple therapy for asthma patients aged 12 and older. The treatment combines ICS, LABA, and LAMA therapies to improve asthma control and reduce exacerbations.
ATxSummit 2026 opened in Singapore with ASEAN youth presenting AI-powered solutions for dementia care, education, and social inclusion. The event highlighted the growing role of AI and edge computing in improving healthcare and community outcomes.
AMR Bio has launched as a clinical-stage biotechnology company focused on preventing post-surgical infections. Its Phase 3-ready XF-73 therapy targets harmful bacteria and addresses the growing challenge of antimicrobial resistance.
Roche secures CE approval for its Elecsys NfL test, enabling earlier detection of neuroinflammation in multiple sclerosis patients.
Cedars-Sinai Guerin Children’s launches LA’s first Neuro NICU, advancing precision neurology and specialized neonatal brain care.
Gargle, Inc. expanded its AI-powered local visibility strategy to help dental practices improve patient trust, online presence, and patient acquisition amid growth in the dental AI screening market.
Pure Infusion unveiled its new brand after merging with AleraCare and Pure Healthcare to enhance patient-focused infusion services. The launch highlights rising growth in the home infusion therapy market.
Bristol Myers Squibb and Hengrui Pharma have announced a major partnership to develop innovative drugs across oncology and immunology, boosting China’s pharmaceutical market growth.
The FDA has approved Ocrevus for pediatric relapsing-remitting multiple sclerosis, expanding treatment options for younger patients.
Discover how AI-driven circular RNA biomarkers are transforming multiple sclerosis diagnostics with faster, more precise detection methods.
Explore how Johnson & Johnson’s Gut Tunnel initiative supports IBD awareness as the gastrointestinal endoscopy market grows through AI-powered diagnostics, minimally invasive procedures, and rising GI disease cases.
Explore how Remepy and Merck KGaA are advancing Hybrid Drugs with AI-powered digital therapeutics as the prescription digital therapeutics market grows through telehealth, wearable technology, and personalized care solutions.
Explore the latest behavioral health care software and services market trends driven by telehealth, AI-powered mental health tools, EHR adoption, and digital patient engagement solutions.
The Europe polypropylene market size is valued at USD 29.99 billion in 2026 and is expected to hit USD 42.50 billion by 2035, exhibiting at a CAGR of 3.95%.
Asia Pacific paints & coatings market size to reach USD 111.05 billion in 2026 and is expected to surpass around USD 182.11 billion by 2035 with a CAGR of 5.65%